Sensei Biotherapeutics Inc Stock
Sensei Biotherapeutics Inc Stock price
Key metrics
| Market capitalization | $11.04m |
| Enterprise Value | $-31.49m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 1.25 |
| P/B ratio (TTM) P/B ratio | 0.24 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-32.48m |
| Free Cash Flow (TTM) Free Cash Flow | $-25.19m |
| Cash position | $47.00m |
Is Sensei Biotherapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.
Sensei Biotherapeutics Inc Stock Analysis
Analyst Opinions
3 Analysts have issued a Sensei Biotherapeutics Inc forecast:
Analyst Opinions
3 Analysts have issued a Sensei Biotherapeutics Inc forecast:
Financial data from Sensei Biotherapeutics Inc
| Sep '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.55 -0.55 |
71%
71%
|
|
| EBITDA | -32 -32 |
18%
18%
|
EBIT (Operating Income) EBIT | -32 -32 |
20%
20%
|
| Net Profit | -30 -30 |
23%
23%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Sensei Biotherapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sensei Biotherapeutics Inc Stock News
Company Profile
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
| Head office | United States |
| CEO | John Celebi |
| Employees | 27 |
| Founded | 1999 |
| Website | senseibio.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
